| View |
|
DRP-310-02
|
Cefuroxime (as sodium)
|
Roxxin
|
750 mg
|
Powder For Injection (I.M/I.V.)
|
-
|
Medchem International Limited
|
India
|
-
|
08 November 2021
|
23 May 2025
|
| View |
|
DRP-1324-01
|
Co-Amoxiclav
|
Co-Ax
|
625mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin/Beta-Lactamase Inhibitor)
|
Sun Pharmaceutical Industries Ltd.
|
India
|
Renewal
|
20 May 2022
|
17 June 2027
|
| View |
|
DRP-10688
|
Methylergometrine maleate
|
Saph-Mem
|
200 mcg/mL
|
Solution for Injection (I.M./I.V.)
|
Oxytocic (Ergot Alkaloid)
|
Kilitch Drugs (India) Ltd.
|
India
|
Initial
|
08 November 2021
|
08 November 2026
|
| View |
|
DRP-10607
|
Valsartan
|
None
|
80 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
22 October 2021
|
22 October 2026
|
| View |
|
DRP-4696-11
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Syprolyd 4.5
|
4 g/500 mg
|
Powder For Injection (I.V)
|
Antibacterial (Penicillin/Beta-Lactamase Inhibitor)
|
Zeiss Pharmaceuticals Pvt. Ltd.
|
India
|
Automatic Renewal
|
11 October 2022
|
05 September 2028
|
| View |
|
DRP-8640-04
|
Azithromycin (as Dihydrate)
|
Hithro
|
500 mg
|
Film-Coated Tablet
|
-
|
Theon Pharmaceuticals Limited
|
India
|
-
|
26 October 2021
|
22 January 2025
|
| View |
|
DRP-10594
|
Latanoprost
|
Latasopt
|
0.01%
|
Ophthalmic Solution
|
-
|
World Medicine Ilac Sanayi Ve Ticaret A.S.
|
Turkey
|
-
|
21 October 2021
|
21 October 2026
|
| View |
|
DR-XY32450
|
Metronidazole
|
Metroxid
|
5 mg/mL (500 mg/100mL)
|
Solution for IV Infusion
|
-
|
Utopian Co., Ltd.
|
Thailand
|
-
|
03 March 2022
|
03 July 2025
|
| View |
|
DR-XY47490
|
Levodropropizine
|
Tussilev
|
30 mg/5 mL
|
Syrup
|
Cough Suppressant
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
22 October 2021
|
22 October 2026
|
| View |
|
DR-XY37891
|
Enalapril Maleate +Hydrochlorothiazide
|
Co-Hypace
|
20 mg/12.5 mg
|
tablet
|
-
|
Pascual Laboratories, Inc.
|
Philippines
|
-
|
08 November 2021
|
04 May 2025
|
| View |
|
DR-XY47492
|
Cisplatin
|
Cisbil
|
1 mg/mL (10 mg/ 10 mL)
|
Concentrate for Solution for
Intravenous Infusion
|
Antineoplastic
|
SP Accure Labs Pvt. Ltd.
|
India
|
Initial
|
26 October 2021
|
26 October 2026
|
| View |
|
DR-XY41240
|
Montelukast (As Sodium)
|
Aurohex
|
5 mg
|
Chewable Tablet
|
Leukotriene Receptor Antagonist
|
Flamingo Pharmaceuticals Ltd.
|
India
|
Renewal
|
20 June 2022
|
11 September 2027
|
| View |
|
DRP-10644
|
Gemcitabine (as Hydrochloride)
|
Gencivenz-1000
|
1g
|
Lyophilized Powder for Injection (IV infusion)
|
Antineoplastic (Pyrimidine Analogue)
|
Shilpa Medicare Limited
|
India
|
Initial
|
26 October 2021
|
26 October 2026
|
| View |
|
DRP-7049-01
|
Etoricoxib
|
Starcox
|
90 mg
|
Film-Coated Tablet
|
COX-2 Selective Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
16 August 2022
|
28 August 2027
|
| View |
|
DRP-10643
|
Gemcitabine (as Hydrochloride)
|
Gencivenz-200
|
200 mg
|
Lyophilized Powder For Injection (IV Infusion)
|
Antineoplastic (Pyrimidine Analogue)
|
Shilpa Medicare Limited
|
India
|
Initial
|
26 October 2021
|
26 October 2026
|
| View |
|
DRP-10590
|
Oxaliplatin
|
Plaxatin
|
50 mg
|
Lyophilized Powder for Injection for I.V.
Infusion
|
-
|
Jari Pharmaceutical Co., Ltd.
|
China
|
-
|
20 October 2021
|
20 October 2026
|
| View |
|
DRHR-2068
|
Hydroquinone + Tretinoin
|
None
|
8.5mg/60mcg per g
|
Topical Cream
|
-
|
Beauche International Manufacturing Corporation
|
Philippines
|
-
|
15 October 2021
|
15 October 2026
|
| View |
|
DRHR-2067
|
Hydroquinone + Tretinoin
|
None
|
11mg/50mcg per mL
|
Topical Solution
|
-
|
Beauche International Manufacturing Corporation
|
Philippines
|
-
|
15 October 2021
|
15 October 2026
|
| View |
|
DRP-10689
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Tazocare
|
4 g / 500 mg
|
Powder for Injection for I.V. Infusion
|
-
|
North China Pharmaceutical Co., Ltd.
|
China
|
-
|
08 November 2021
|
08 November 2026
|
| View |
|
DRP-10667
|
Losartan Potassium
|
Saphlor-50
|
50 mg
|
Film-Coated Tablet
|
-
|
Sapphire Lifesciences Ltd. Pvt.
|
India
|
-
|
03 November 2021
|
03 November 2026
|